Abstract
Itch is a common sensory experience that is prevalent in patients with inflammatory skin diseases, as well as in those with systemic and neuropathic conditions. In patients with these conditions, itch is often severe and significantly affects quality of life. Itch is encoded by 2 major neuronal pathways: histaminergic (in acute itch) and nonhistaminergic (in chronic itch). In the majority of cases, crosstalk existing between keratinocytes, the immune system, and nonhistaminergic sensory nerves is responsible for the pathophysiology of chronic itch. This review provides an overview of the current understanding of the molecular, neural, and immune mechanisms of itch: beginning in the skin, proceeding to the spinal cord, and eventually ascending to the brain, where itch is processed. A growing understanding of the mechanisms of chronic itch is expanding, as is our pipeline of more targeted topical and systemic therapies. Our therapeutic armamentarium for treating chronic itch has expanded in the last 5 years, with developments of topical and systemic treatments targeting the neural and immune systems.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1375-1390 |
| Number of pages | 16 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 142 |
| Issue number | 5 |
| DOIs | |
| State | Published - Nov 1 2018 |
Fingerprint
Keywords
- Itch
- management
- mechanism
- pathophysiology
- pruritus
- treatment
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Cite this
Itch : From mechanism to (novel) therapeutic approaches. / Yosipovitch, Gil; Rosen, Jordan Daniel; Hashimoto, Takashi.
In: Journal of Allergy and Clinical Immunology, Vol. 142, No. 5, 01.11.2018, p. 1375-1390.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Itch
T2 - From mechanism to (novel) therapeutic approaches
AU - Yosipovitch, Gil
AU - Rosen, Jordan Daniel
AU - Hashimoto, Takashi
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Itch is a common sensory experience that is prevalent in patients with inflammatory skin diseases, as well as in those with systemic and neuropathic conditions. In patients with these conditions, itch is often severe and significantly affects quality of life. Itch is encoded by 2 major neuronal pathways: histaminergic (in acute itch) and nonhistaminergic (in chronic itch). In the majority of cases, crosstalk existing between keratinocytes, the immune system, and nonhistaminergic sensory nerves is responsible for the pathophysiology of chronic itch. This review provides an overview of the current understanding of the molecular, neural, and immune mechanisms of itch: beginning in the skin, proceeding to the spinal cord, and eventually ascending to the brain, where itch is processed. A growing understanding of the mechanisms of chronic itch is expanding, as is our pipeline of more targeted topical and systemic therapies. Our therapeutic armamentarium for treating chronic itch has expanded in the last 5 years, with developments of topical and systemic treatments targeting the neural and immune systems.
AB - Itch is a common sensory experience that is prevalent in patients with inflammatory skin diseases, as well as in those with systemic and neuropathic conditions. In patients with these conditions, itch is often severe and significantly affects quality of life. Itch is encoded by 2 major neuronal pathways: histaminergic (in acute itch) and nonhistaminergic (in chronic itch). In the majority of cases, crosstalk existing between keratinocytes, the immune system, and nonhistaminergic sensory nerves is responsible for the pathophysiology of chronic itch. This review provides an overview of the current understanding of the molecular, neural, and immune mechanisms of itch: beginning in the skin, proceeding to the spinal cord, and eventually ascending to the brain, where itch is processed. A growing understanding of the mechanisms of chronic itch is expanding, as is our pipeline of more targeted topical and systemic therapies. Our therapeutic armamentarium for treating chronic itch has expanded in the last 5 years, with developments of topical and systemic treatments targeting the neural and immune systems.
KW - Itch
KW - management
KW - mechanism
KW - pathophysiology
KW - pruritus
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85055722622&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055722622&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2018.09.005
DO - 10.1016/j.jaci.2018.09.005
M3 - Review article
VL - 142
SP - 1375
EP - 1390
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 5
ER -